CGB 7.14% 0.8¢ cann global limited

Ann: Q&A on the merger of QBL MCL and Medcan, page-542

  1. 158 Posts.
    lightbulb Created with Sketch. 19
    I didn't have a pessimistic view of MCL when I invested and still think it has great potential. I bought shares in QBL with the enticement of priority in the IPO of MCL.
    An IPO would have given an opportunity through prospectus to fully review and analyse the current state and future possibilities.
    I view MCL as fledgling because it is not fully developed and its because of its potential when it is fully fledged that I invested.
    What you incorrectly interpret as a pessimistic view has developed after this latest Ann , the content of the Ann, how it was all handled, how it is being handled has led to what I would describe as a combination of disappointment and disillusionment not pessimism.
    MCL had and still has great promise but IMO it is nowhere near its full potential at the moment and the manner in which these deals were struck, the ASX complications, the value attributed to 45% of the current MCL, the price @ 0.08 for the CR , puts at risk MCL ever reaching it.
    Good communication channels with a company that you are invested in is great, however IMO the seeming reliance on social media to gauge or guide the sentiment on a company(and also IMO getting it totally wrong) instead of presenting a polished, professional investor presentation and letting facts speak for themselves needs to be addressed.
    I am hoping that the prospectus for CR gives the required detail, that it is clear where MCL is now, where it is headed and how it is going to get there without any aggrandisement or "fluff" as another poster put it.
 
watchlist Created with Sketch. Add CGB (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.